Your browser doesn't support javascript.
loading
Fluoroquinolones and isoniazid-resistant tuberculosis: implications for the 2018 WHO guidance.
Stagg, Helen R; Bothamley, Graham H; Davidson, Jennifer A; Kunst, Heinke; Lalor, Maeve K; Lipman, Marc C; Loutet, Miranda G; Lozewicz, Stefan; Mohiyuddin, Tehreem; Abbara, Aula; Alexander, Eliza; Booth, Helen; Creer, Dean D; Harris, Ross J; Kon, Onn Min; Loebinger, Michael R; McHugh, Timothy D; Milburn, Heather J; Palchaudhuri, Paramita; Phillips, Patrick P J; Schmok, Erik; Taylor, Lucy; Abubakar, Ibrahim.
Afiliação
  • Stagg HR; Institute for Global Health, University College London, London, UK helen.stagg@ed.ac.uk.
  • Bothamley GH; Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UK.
  • Davidson JA; Respiratory Medicine, Homerton University Hospital, London, UK.
  • Kunst H; These authors contributed equally to this manuscript and are presented alphabetically.
  • Lalor MK; Tuberculosis Unit, National Infection Service, Public Health England, London, UK.
  • Lipman MC; These authors contributed equally to this manuscript and are presented alphabetically.
  • Loutet MG; Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Lozewicz S; These authors contributed equally to this manuscript and are presented alphabetically.
  • Mohiyuddin T; Institute for Global Health, University College London, London, UK.
  • Abbara A; Tuberculosis Unit, National Infection Service, Public Health England, London, UK.
  • Alexander E; These authors contributed equally to this manuscript and are presented alphabetically.
  • Booth H; Respiratory Medicine, Royal Free Hospital, London, UK.
  • Creer DD; UCL Respiratory, Division of Medicine, University College London.
  • Harris RJ; These authors contributed equally to this manuscript and are presented alphabetically.
  • Kon OM; Tuberculosis Unit, National Infection Service, Public Health England, London, UK.
  • Loebinger MR; These authors contributed equally to this manuscript and are presented alphabetically.
  • McHugh TD; Respiratory Medicine, North Middlesex University Hospital, London, UK.
  • Milburn HJ; These authors contributed equally to this manuscript and are presented alphabetically.
  • Palchaudhuri P; Tuberculosis Unit, National Infection Service, Public Health England, London, UK.
  • Phillips PPJ; These authors contributed equally to this manuscript and are presented alphabetically.
  • Schmok E; Infectious Diseases, London North West University Healthcare NHS Trust, London, UK.
  • Taylor L; These authors contributed equally to this manuscript and are presented alphabetically.
  • Abubakar I; National Mycobacterial Reference Service South, Public Health England, London, UK.
Eur Respir J ; 54(4)2019 10.
Article em En | MEDLINE | ID: mdl-31371444
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirazinamida / Rifampina / Tuberculose Resistente a Múltiplos Medicamentos / Fluoroquinolonas / Etambutol / Levofloxacino / Antituberculosos Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirazinamida / Rifampina / Tuberculose Resistente a Múltiplos Medicamentos / Fluoroquinolonas / Etambutol / Levofloxacino / Antituberculosos Idioma: En Ano de publicação: 2019 Tipo de documento: Article